CRISPR and infertility: what the research can and cannot do

CRISPR is a gene-editing tool that lets scientists change DNA at specific locations. It has changed how researchers study the genetics of reproduction. But it is important to be clear: there are no CRISPR-based infertility treatments available to patients, and editing human embryos for pregnancy is not an approved treatment.

How researchers use CRISPR today

According to MedlinePlus, genome editing is currently used mostly in cells and animal models in research labs to understand diseases. In reproductive science, this means researchers can switch off specific genes in animals to see how that affects egg, sperm, or embryo development. That helps identify genes that may be involved in some forms of infertility.

Why embryo editing is not a treatment

Changes made to genes in eggs, sperm, or embryos (germline editing) can be passed on to future generations. MedlinePlus notes that germline and embryo genome editing are currently illegal in the United States and many other countries. The National Human Genome Research Institute explains that most ethical debate about genome editing centers on the germline because of these inherited effects.

Key open questions

• Safety: Edits may be incomplete or occur in the wrong place, and the long-term effects are unknown.
• Consent: Future generations affected by a germline change cannot consent to it.
• Need: Many causes of infertility are not genetic at all, such as blocked fallopian tubes or ovulation problems, and existing treatments address these.

What this means for patients today

If a known genetic condition runs in your family, today's options include genetic counselling and, in some cases, preimplantation genetic testing of IVF embryos, which tests embryos without changing their DNA. Be cautious of any clinic or company offering "gene-edited" fertility treatment. CRISPR research may improve understanding of infertility over time, but it is a research tool, not a treatment.